Phentermine 3.75 mg / topiramate 23 mg 24HR Extended Release Oral Capsule
RxNorm 1302839
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1302839 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: phentermine 3.75 mg / topiramate 23 mg 24HR Extended Release Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
24 HR phentermine 3.75 mg / topiramate 23 mg Extended Release Oral Capsule
(Atom ID: 12347890)
SYPrescribable
Synonym (SY):
Phentermine 3.75 mg / topiramate 23 mg 24 HR Extended Release Oral Capsule
(Atom ID: 6354432)
PSNPrescribable
Prescribable Name (PSN):
Phentermine 3.75 mg / topiramate 23 mg 24HR Extended Release Oral Capsule
(Atom ID: 6365546)
Patient Education
Phentermine and Topiramate
Phentermine and topiramate extended-release (long-acting) capsules are used to help adults who are obese or who are overweight and have weight-related medical problems to lose weight and to keep from gaining back that weight. Phentermine and topiramate extended-release capsules must be used along with a reduced calorie diet and exercise plan. Phentermine is in a class of medications called anorectics. It works by decreasing appetite. Topiramate is in a class of medications called anticonvulsants. It works by decreasing appetite and by causing feelings of fullness to last longer after eating.
[Learn More]
* Please review the disclaimer below.